Synthesis and in vitro antiprotozoal activity of bisbenzofuran cations

Journal of Medicinal Chemistry

Volumn 50, Issue 23, 2007, Pages 5807-5823

  Bakunova, Svetlana M ^a   Bakunov, Stanislav A ^a   Wenzler, Tanja ^b   Barszcz, Todd ^c   Werbovetz, Karl A ^c   Brun, Reto ^b   Hall, James Edwin ^a   Tidwell, Richard R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 AMIDINOBENZOFURAN 2 YL) 2 (6 AMINIDINOBENZOFURAN 2 YL)ETHANE; 1 (5 N ISOPROPYLAMIDINOBENZOFURAN 2 YL) 2 (6 N ISOPROPYLAMIDINOBENZOFURAN 2 YL)ETHANE; 1 [5 (2 IMIDAZOLINYL)BENZOFURANYL] 2 [6 (2 IMIDAZOLINYL)BENZOFURAN 2 YL]ETHANE; 1,2 BIS(5 AMIDINOBENZOFURAN 2 YL)ETHANE; 1,2 BIS(6 AMIDINOBENZOFURAN 2 YL)ETHANE; 1,2 BIS[5 (N ISOPROPYL)AMIDINOBENZOFURAN 2 YL]ETHANE; 1,2 BIS[6 (N ISOPROPYL)AMIDINOBENZOFURAN 2 YL]ETHANE; 1,3 BIS[5 (2 IMIDAZOLINYL)BENZOFURAN 2 YL]PROPANE; 1,4 BIS(5 AMIDINOBENZOFURAN 2 YL)BUTANE; 1,4 BIS[5 (2 IMIDAZOLINYL)BENZOFURAN 2 YL]BUTANE; 1,4 BIS[5 (N ISOPROPYL)AMIDINOBENZOFURAN 2 YL]BUTANE; 1,5 BIS[5 (N ISOPROPYL)IMIDINOBENZOFURAN 2 YL]PENTANE; ACETYLENE DERIVATIVE; ARTEMISININ; BENZOFURAN DERIVATIVE; BIS(2 AMIDINOBENZOFURAN 2 YL)METHANE; BIS[5 (2 IMIDAZOLINYL)BENZOFURAN 2 YL]METHANE; BISBENZOFURAN DERIVATIVE; CARBON; CATION; COPPER; HALOGEN; HYDROXYALDEHYDE; KETONE DERIVATIVE; MELARSOPROL; PALLADIUM; PENTAMIDINE; PHENOL DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANNULATION REACTION; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; LEISHMANIA DONOVANI; MAMMAL CELL; NONHUMAN; PLASMODIUM FALCIPARUM; REACTION ANALYSIS; STRUCTURE ANALYSIS; TRYPANOSOMA RHODESIENSE;

ANIMALS; ANTIMALARIALS; BENZOFURANS; CATIONS; LEISHMANIA DONOVANI; PLASMODIUM FALCIPARUM; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI RHODESIENSE;

EID: 36148982213     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0708634     Document Type: Article

References (90)

1. Barrett, M. P. The fall and rise of sleeping sickness. Lancet 1999, 353, 1113-1114.
2. Legros, D.; Ollivier, G.; Gastellu-Etchegorry, M.; Paquet, C.; Burri, C.; Jannin, J.; Buscher, P. Treatment of human African trypanosomiasis-present situation and needs for research and development. Lancet Infect. Dis. 2002, 2, 437-440.
3. Bloland, P. B. Drug resistance in malaria. http://www.who.int/csr/ resources/publications/drugresist/malaria.pdf (accessed May 2007).
4. Choi, C. M.; Lerner, E. A. Leishmaniasis as an emerging infection. J. Investig. Dermatol. Symp. Proc. 2001, 6, 175-182.
5. Greenwood, B.; Mutabingwa, T. Malaria in 2002. Nature 2002, 415, 670-672.
6. Brun, R.; Balmer, O. New developments in human African trypanosomiasis. Curr. Opin. Infect. Dis. 2006, 19, 415-420.
7. Fairlamb, A. H. Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol. 2003, 19, 488-494.
8. Burri, C.; Brun, R. Human African Trypanosomiasis. In Manson's Tropical Diseases; Cook, G. C.; Zumla, A., Eds.; W. B. Saunders: London 2003; pp 1303-1323.
9. WHO. African trypanosomiasis (sleeping sickness). http://www.who.int/ mediacentre/factsheets/fs259/en/(accessed May 2007).
10. Cruz, I.; Nieto, J.; Moreno, J.; Canavate, C.; Desjeux, P.; Alvar, J. Leishmania/HIV co-infections in the second decade. Indian J. Med. Res. 2006, 123, 357-388.
11. Wolday, D.; Berhe, N.; Akuffo, H.; Desjeux, P.; Britton, S. Emerging Leishmania/HIV co-infection in Africa. Med. Microbiol. Immunol. 2001, 190, 65-67.
12. Rabello, A.; Orsini, M.; Disch, J. Leishmania/HIV co-infection in Brazil: an appraisal. Ann. Trop. Med. Parasitol. 2003, 97 Suppl 1, 17-28.
13. Pintado, V.; Lopez-Velez, R. HIV-associated visceral leishmaniasis. Clin. Microbiol. Infection 2001, 7, 291-300.
14. Desjeux, P.; Alvar, J. Leishmania/HIV co-infections: epidemiology in Europe. Ann. Trop. Med. Parasitol. 2003, 97 Suppl I, 3-15.
15. Weina, P. J.; Neafie, R. C.; Wortmann, G.; Polhemus, M.; Aronson, N. E. Old world leishmaniasis: an emerging infection among deployed US military and civilian workers. Clin. Infect. Dis. 2004, 39, 1674-1680.
16. May, J.; Meyer, C. G. Chemoresistance in falciparum malaria. Trends Parasitol. 2003, 19, 432-435; discussion 435-436.
17. Biagini, G. A.; O'Neill, P. M.; Bray, P. G.; Ward, S. A. Current drug development portfolio for antimalarial therapies. Curr. Opin. Pharmacol. 2005, 5, 473-478.
18. Woodrow, C. J.; Krishna, S. Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance. Cell. Mol. Life Sci. 2006, 63, 1586-1596.
19. Le Bras, J.; Durand, R. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam. Clin. Pharmacol. 2003, 17, 147-153.
20. Hyde, J. E. Drug-resistant malaria. Trends Parasitol. 2005, 21, 494-498.
21. Arav-Boger, R.; Shapiro, T. A. Molecular mechanisms of resistance in antimalarial chemotherapy: the unmet challenge. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 565-585.
22. Burchmore, R. J.; Ogbunude, P. O.; Enanga, B.; Barrett, M. P. Chemotherapy of human African trypanosomiasis. Curr. Pharm. Des. 2002, 8, 257-267.
23. Docampo, R.; Moreno, S. N. Current chemotherapy of human African trypanosomiasis. Parasitol. Res. 2003, 90 Supp 1, S10-13.
24. Ouellette, M.; Drummelsmith, J.; Papadopoulou, B. Leishmaniasis: Drugs in the clinic, resistance and new developments. Drug Resist. Update 2004, 7, 257-266.
25. Werbovetz, K. Promising therapeutic targets for antileishmanial drugs. Expert Opin. Ther. Targets 2002, 6, 407-422.
26. Sundar, S.; More, D.; Singh, M.; Singh, V.; Sharma, S.; Makharia, A.; Kumar, P.; Murray, H. Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic. Clin. Infect. Dis. 2000, 31, 1104-1107.
27. Singh, S.; Sivakumar, R. Challenges and new discoveries in the treatment of leishmaniasis. J. Infect. Chemother. 2004, 10, 307-315.
28. Das, B. P.; Boykin, D. W. Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)furans. J. Med. Chem. 1977, 20, 531-536.
29. Anne, J.; De Clercq, E.; Eyssen, H.; Dann, O. Antifungal and antibacterial activities of diarylamidine derivatives. Antimicrob. Agents Chemother. 1980, 18, 231-239.
30. Bell, C. A.; Hall, J. E.; Kyle, D. E.; Grogl, M.; Ohemeng, K. A.; Allen, M. A.; Tidwell, R. R. Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. Antimicrob. Agents Chemother. 1990, 34, 1381-1386.
31. Tidwell, R. R.; Jones, S. K.; Geratz, J. D.; Ohemeng, K. A.; Cory, M.; Hall, J. E. Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. J. Med. Chem. 1990, 33, 1252-1257.
32. Brendle, J. J.; Outlaw, A.; Kumar, A.; Boykin, D. W.; Patrick, D. A.; Tidwell, R. R.; Werbovetz, K. A. Antileishmanial activities of several classes of aromatic dications. Antimicrob. Agents Chemother. 2002, 46, 797-807.
33. Ismail, M. A.; Brun, R.; Easterbrook, J. D.; Tanious, F. A.; Wilson, W. D.; Boykin, D. W. Synthesis and antiprotozoal activity of aza-analogues of furamidine. J. Med. Chem. 2003, 46, 4761-4769.
34. Bouteille, B.; Oukem, O.; Bisser, S.; Dumas, M. Treatment perspectives for human African trypanosomiasis. Fundam. Clin. Pharmacol. 2003, 17, 171-181.
35. Barrett, M. P.; Fairlamb, A. H. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitol. Today 1999, 15, 136-140.
36. Carter, N. S.; Berger, B. J.; Fairlamb, A. H. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J. Biol. Chem. 1995, 270, 28153-28157.
37. Bray, P. G.; Barrett, M. P.; Ward, S. A.; de Koning, H. P. Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol. 2003, 19, 232-239.
38. Stead, A. M.; Bray, P. G.; Edwards, I. G.; de Koning, H. P.; Elford, B. C.; Stocks, P. A.; Ward, S. A. Diamidine compounds: selective uptake and targeting in Plasmodium falciparum. Mol. Pharmacol. 2001, 59, 1298-1306.
39. de Koning, H. P. Transporters in African trypanosomes: role in drug action and resistance. Int. J. Parasitol. 2001, 31, 512-522.
40. de Koning, H. P.; Jarvis, S. M. Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs. Mol. Pharmacol. 1999, 56, 1162-1170.
41. Carter, N. S.; Barrett, M. P.; de Koning, H. P. A drug resistance determinant in Trypanosoma brucei. Trends Microbiol. 1999, 7, 469-471.
42. Zhang, X.; Berger, B. J.; Ulrich, P. Synthesis and trypanocidal activity of the bis-carba analogue of pentamidine. Bioorg. Med. Chem. Lett. 1996, 6, 1035-1036.
43. Dann, O.; Fernbach, R.; Pfeifer, W.; Demant, E.; Bergen, G.; Lang, S.; Lurding, G. Trypanocide diamidine mit drei ringen in zwei isolierten ringsystemen. Liebigs Ann. Chem. 1972, 760, 37-87.
44. Dann, O.; Volz, G.; Demant, E.; Pfeifer, W.; Bergen, G.; Fick, H.; Walkenhorst, E. Trypanocide diamidine mit vier ringen in einem oder zwei ringsystemen. Liebigs Ann. Chem. 1973, 1112-1140.
45. Dann, O.; Char, H.; Griebmeier, H. Synthesen biskationisher, trypanocider 1-benzofuran-verbindungen. Liebigs Ann. Chem. 1982, 1836-1869.
46. Guillaumel, J.; Royer, R. Synthese d'ethers diethylamino ethyliques de bibenzofurannes et de bis-benzofuryl cetones, comme analogues pharmacochimiques de la Tilorone. J. Heterocycl. Chem. 1986, 23, 1277-1282.
47. Doad, G. J. S.; Barltrop, J. A.; Petty, C. M.; Owen, T. C. A versatile and convenient synthesis of benzofurans. Tetrahedron Lett. 1989, 30, 1597-1598.
48. Pilling, R. J.; Whiting, D. A. FIQ and FIQ2, New Q-site inhibitors for photosynthetic electron transport: synthesis and the relationship between stereochemistry and biological activity. J. Chem. Soc. Perkin Trans. 1 1999, 2077-2086.
49. Castro, C. E.; Gaughan, E. J.; Owsley, D. C. Indoles, benzofurans, phthalides, and tolanes via copper(I) acetylides. J. Org. Chem. 1966, 31, 4071-4078.
50. Castro, C. E.; Havlin, R.; Honwad, V. K.; Malte, A. M.; Moje, S. W. Copper(I) substitutions. Scope and mechanism of cuprous acetylide substitutions. J. Am. Chem. Soc. 1969, 91, 6464-6470.
51. Sonogashira, K.; Tohda, Y.; Hagihara, N. A convenient synthesis of acetylenes: catalytic substitutions of acetylenic hydrogen with bromoalkenes, iodoarenes and bromopyridines. Tetrahedron Lett. 1975, 16, 4467-4470.
52. Fancelli, D.; Fagnola, M. D.; Severino, D.; Bedeschi, A. Solid phase synthesis of 2-substituted benzofurans via the palladium-catalysed heteroannulation of acetylenes. Tetrahedron Lett. 1997, 38, 2311-2314.
53. Katritzky, A. R.; Fali, C. N.; Li, J. General synthesis of polysubstituted benzo[β]furans. J. Org. Chem. 1997, 62, 8205-8209.
54. Kundu, N. G.; Pal, M.; Mahanty, J. S.; De, M. Palladium-catalysed heteroannulation with acetylenic compounds: synthesis of benzofurans. J. Chem. Soc., Perkin Trans. 1 1997, 2815-2820.
55. Lutjens, H.; Scammells, P. J. Synthesis of natural products possessing a benzo[β]furan skeleton. Tetrahedron Lett. 1998, 39, 6581-6584.
56. Inoue, M.; Carson, M. W.; Frontier, A. J.; Danishefsky, S. J. Total synthesis and determination of absolute configuration of frondosin B. J. Am. Chem. Soc. 2001, 123, 1878-1889.
57. 2-carbon halides. J. Organomet. Chem. 2002, 653, 46-49.
58. Kobayashi, S.; Azekawa, M.; Morita, H. The Reimer-Tiemann reaction of m-halophenols. II. With m-bromophenol. Chem. Pharm. Bull. 1969, 17, 89-93.
59. Edgar, K. J.; Falling, S. N. An efficient and selective method for the preparation of iodophenols. J. Org. Chem. 1990, 55, 5287-5291.
60. Diaz, P.; Gendre, F.; Stella, L.; Charpentier, B. New synthetic retinoids obtained by palladium-catalyzed tandem cyclisation-hydride capture process. Tetrahedron 1998, 54, 4579-4590.
61. Sagi, K.; Nakagawa, T.; Yamanashi, M.; Makino, S.; Takahashi, M.; Takayanagi, M.; Takenaka, K.; Suzuki, N.; Oono, S.; Kataoka, N.; Ishikawa, K.; Shima, S.; Fukuda, Y.; Kayahara, T.; Takehana, S.; Shima, Y.; Tashiro, K.; Yamamoto, H.; Yoshimoto, R.; Iwata, S.; Tsuji, T.; Sakurai, K.; Shoji, M. Rational design, synthesis, and structure-activity relationships of novel factor Xa inhibitors: (2-substituted-4-amidinophenyl)pyruvic and -propionic acids. J. Med. Chem. 2003, 46, 1845-1857.
62. Mancuso, A. J.; Swern, D. Activated dimethyl sulfoxide: useful reagents for synthesis. Synthesis 1981, 165-185.
63. Muller, S.; Liepold, B.; Roth, G. J.; Bestmann, H. J. An improved one-pot procedure for the synthesis of alkynes from aldehydes. Synlett 1996, 521-522.
64. Callant, P. D. H. L.; Vandewalle, M. An efficient preparation and the intramolecular cyclopropanation of α-diazo-β-ketophosphonates and α-diazophoshonoacetates. Synth. Commun. 1984, 14, 155-161.
65. Kitamura, M.; Tokunaga, M.; Noyori, R. Asymmetric hydrogenation of β-keto phosphonates: a practical way to fosfomycin. J. Am. Chem. Soc. 1995, 117, 2931-2932.
66. Wood, J. L.; Khatri, N. A.; Weinreb, S. M. A direct conversion of esters to nitriles. Tetrahedron Lett. 1979, 20, 4907-4910.
67. Verner, E.; Katz, B. A.; Spencer, J. R.; Allen, D.; Hataye, J.; Hruzewicz, W.; Hui, H. C.; Kolesnikov, A.; Li, Y.; Luong, C.; Martelli, A.; Radika, K.; Rai, R.; She, M.; Shrader, W.; Sprengeler, P. A.; Trapp, S.; Wang, J.; Young, W. B.; Mackman, R. L. Development of serine protease inhibitors displaying a multicentered short (<2.3 Å) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa. J. Med. Chem. 2001, 44, 2753-2771.
68. Hellbach, B.; Gleiter, R.; Rominger, F. Cyclic diynes by alkyne metathesis. Synthesis 2003, 2535-2541.
69. Dox, A. W.; Whitmore, F. C. Acetamidine Hydrochloride. In Organic Syntheses, 2nd ed.; Blatt, A. H., Ed.; John Wiley & Sons: New York, 1941; Vol. 1, pp 5-7.
70. Kaminsky, R.; Schmid, C.; Brun, R. An "in vitro selectivity index" for evaluation of cytotoxicity of antitrypanosomal compounds. In Vitro Toxicol. 1996, 9, 315-324.
71. Soeiro, M. N.; De Souza, E. M.; Stephens, C. E.; Boykin, D. W. Aromatic diamidines as antiparasitic agents. Expert Opin. Investig. Drugs 2005, 14, 957-972.
72. Carter, N. S.; Fairlamb, A. H. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature 1993, 361, 173-176.
73. de Koning, H. P. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: implications for cross-resistance with arsenicals. Mol. Pharmacol. 2001, 59, 586-592.
74. Matovu, E.; Stewart, M. L.; Geiser, F.; Brun, R.; Maser, P.; Wallace, L. J.; Burchmore, R. J.; Enyaru, J. C.; Barrett, M. P.; Kaminsky, R.; Seebeck, T.; de Koning, H. P. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Eukaryot. Cell. 2003, 2, 1003-1008.
75. Rollo, I. M.; Williamson, J. Acquired resistance to 'Melarsen', tryparsamide and amidines in pathogenic trypanosomes after treatment with 'Melarsen' alone. Nature 1951, 167, 147-148.
76. Fairlamb, A. H.; Carter, N. S.; Cunningham, M.; Smith, K. Characterization of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol. Biochem. Parasitol. 1992, 53, 213-222.
77. Pospichal, H.; Brun, R.; Kaminsky, R.; Jenni, L. Induction of resistance to melarsenoxide cysteamine (Mel Cy) in Trypanosoma brucei brucei. Acta Trop. 1994, 58, 187-197.
78. de Koning, H. P.; Jarvis, S. M. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter. Acta Trop. 2001, 80, 245-250.
79. Steck, E. A.; Kinnamon, K. E.; Rane, D. S.; Hanson, W. L. Leishmania donovani, Plasmodium berghei, Trypanosoma rhodesiense: antiprotozoal effects of some amidine types. Exp. Parasitol. 1981, 52, 404-413.
80. Donkor, I. O.; Assefa, H.; Rattendi, D.; Lane, S.; Vargas, M.; Goldberg, B.; Bacchi, C. Trypanocidal activity of dicationic compounds related to pentamidine. Eur. J. Med. Chem. 2001, 36, 531-538.
81. Donkor, I. O.; Huang, T. L.; Tao, B.; Rattendi, D.; Lane, S.; Vargas, M.; Goldberg, B.; Bacchi, C. Trypanocidal activity of conformationally restricted pentamidine congeners. J. Med. Chem. 2003, 46, 1041-1048.
82. Klenke, B.; Stewart, M.; Barrett, M. P.; Brun, R.; Gilbert, I. H. Synthesis and biological evaluation of s-triazine substituted polyamines as potential new anti-trypanosomal drugs. J. Med. Chem. 2001, 44, 3440-3452.
83. Baliani, A.; Bueno, G. J.; Stewart, M. L.; Yardley, V.; Brun, R.; Barrett, M. P.; Gilbert, I. H. Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites. J. Med. Chem. 2005, 48, 5570-5579.
84. Kirk, K. Membrane transport in the malaria-infected erythrocyte. Physiol. Rev. 2001, 81, 495-537.
85. Sperandeo, N. R.; Brun, R. Synthesis and biological evaluation of pyrazolylnaphthoquinones as new potential antiprotozoal and cytotoxic agents. Chembiochem 2003, 4, 69-72.
86. Raz, B.; Iten, M.; Grether-Buhler, Y.; Kaminsky, R.; Brun, R. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro. Acta Trop. 1997, 68, 139-147.
87. Baltz, T.; Baltz, D.; Giroud, C.; Crockett, J. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J. 1985, 4, 1273-1277.
88. Matile, H.; Pink, J. R. L. Plasmodium falciparum malaria parasite culture and their use in immunology. In Immunological Methods; Academic Press: San Diego, 1990; pp 221-234.
89. Werbovetz, K.; Brendle, J.; Sackett, D. Purification, characterization, and drug susceptibility of tubulin from Leishmania. Mol. Biochem. Parasitol. 1999, 98, 53-65.
90. Werbovetz, K.; Sackett, D.; Delfin, D.; Bhattacharya, G.; Salem, M.; Obrzut, T.; Rattendi, D.; Bacchi, C. Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfonilamide (GB-II-5) against kinetoplastid parasites. Mol. Pharm. 2003, 64, 1325-1333.